ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 13 Jun 2022
Last Applicant/ Owned by
Barnahely
Ringaskiddy, Co. Cork
IE
Serial Number
88163567 filed on 22nd Oct 2018
Registration Number
N/A
Correspondent Address
Cheryl L. Foytlin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ERVOIK
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory dis Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Mark Details
Serial Number
No 88163567
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T44231US1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Jun 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 13th Jun 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 03rd Nov 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th Nov 2021 | SOU EXTENSION 5 GRANTED |
| 02th Nov 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 26th Oct 2021 | SOU EXTENSION 5 FILED |
| 26th Oct 2021 | TEAS EXTENSION RECEIVED |
| 31st Mar 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Mar 2021 | SOU EXTENSION 4 GRANTED |
| 29th Mar 2021 | SOU EXTENSION 4 FILED |